📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Scil Proteins

1.1 - Company Overview

Scil Proteins Logo

Scil Proteins

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery and development of Affilin molecules and partnerships for the development and manufacture of protein therapeutics and diagnostics. Affilin molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin, forming highly stable molecules.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Scil Proteins

Signal Pharmaceuticals Logo

Signal Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions, headquartered in San Diego, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Signal Pharmaceuticals company profile →
Arzeda Logo

Arzeda

HQ: United States Website
  • Description: Provider of AI-driven protein and enzyme design and manufacturing for pharmaceuticals, industrial chemicals, and food applications. Offers Intelligent Protein Design Technology to create novel proteins; ProSweet enzymes for efficient production of Reb D and Reb M from stevia; and collaborates with Unilever (cleaning), W. L. Gore (materials), Takeda (therapeutic biologics), and AAK (plant-based oils).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arzeda company profile →
Numerate Logo

Numerate

HQ: United States Website
  • Description: Provider of cloud-scale machine-learning-driven drug design and discovery, with a computational platform that predicts how potential drugs will behave in the lab and the body, combining data science, machine learning, cloud analytics, and medicinal chemistry.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Numerate company profile →
Perfectus Biomed Logo

Perfectus Biomed

HQ: United Kingdom Website
  • Description: Provider of U.K.-based microbiological services with a research-driven approach to testing, rapid turnaround, and personalized service, specializing in bespoke assays and biofilm testing. Offers biological safety consulting, clinical research for medical devices, IVD services, product development strategy, quality and regulatory consulting, and the NAMSA APEX Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Perfectus Biomed company profile →
Evitria Logo

Evitria

HQ: Switzerland Website
  • Description: Provider of global antibody expression services specialized in CHO-based transient production of recombinant antibodies, including chimeric, bispecific, Fc-optimized, fusion, afucosylated (GlymaxX) and Fc-silenced (STR) variants. Offers bispecific formats (Duobody, IgG-scFvs, Knobs-into-Holes) and transient expression of secreted proteins (scFvs, extracellular domains, cytokines, viral proteins).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Evitria company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Scil Proteins

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Scil Proteins

2.2 - Growth funds investing in similar companies to Scil Proteins

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Scil Proteins

4.2 - Public trading comparable groups for Scil Proteins

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Scil Proteins

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Scil Proteins

What does Scil Proteins do?

Scil Proteins is a provider of discovery and development of Affilin molecules and partnerships for the development and manufacture of protein therapeutics and diagnostics. Affilin molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin, forming highly stable molecules.

Who are Scil Proteins's competitors?

Scil Proteins's competitors and similar companies include Signal Pharmaceuticals, Arzeda, Numerate, Perfectus Biomed, and Evitria.

Where is Scil Proteins headquartered?

Scil Proteins is headquartered in Germany.

How many employees does Scil Proteins have?

Scil Proteins has 1,000 employees 🔒.

When was Scil Proteins founded?

Scil Proteins was founded in 2010 🔒.

What sector and industry vertical is Scil Proteins in?

Scil Proteins is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Scil Proteins

Who are the top strategic acquirers in Scil Proteins's sector and industry

Top strategic M&A buyers and acquirers in Scil Proteins's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Scil Proteins?

Top strategic M&A buyers groups and sectors for Scil Proteins include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Scil Proteins's sector and industry vertical

Which are the top PE firms investing in Scil Proteins's sector and industry vertical?

Top PE firms investing in Scil Proteins's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Scil Proteins's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Scil Proteins's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Scil Proteins's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Scil Proteins include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Scil Proteins's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Scil Proteins?

The key public trading comparables and valuation benchmarks for Scil Proteins include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Scil Proteins for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Scil Proteins with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Scil Proteins's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Scil Proteins with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Scil Proteins's' sector and industry vertical?

Access recent funding rounds and capital raises in Scil Proteins's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Scil Proteins